David Coeffic
Impact in
-
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 21
- Cancer Treatment and Pharmacology 13
- HER2/EGFR in Cancer Research 7
- Colorectal Cancer Treatments and Studies 3
- Neutropenia and Cancer Infections 3
-
- Breast Cancer Treatment Studies 9
- Co-authors
- David Khayat (2 shared papers)Laurent Arnould (6 shared papers)Bruno Coudert (6 shared papers)Éric-Charles Antoine (1 shared paper)Mario Campone (3 shared papers)Frank Priou (2 shared papers)Joseph Gligorov (3 shared papers)V. Trillet-Lenoir (2 shared papers)
In The Last Decade
David Coeffic
33 papers receiving 470 citations
Peers
Comparison fields: 5 of 62
- Cancer Research 139
- Oncology 234
- Reproductive Medicine 45
- Radiology, Nuclear Medicine and Imaging 75
- Complementary and alternative medicine 20
Countries citing papers authored by David Coeffic
This map shows the geographic impact of David Coeffic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Coeffic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Coeffic more than expected).
Fields of papers citing papers by David Coeffic
This network shows the impact of papers produced by David Coeffic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Coeffic. The network helps show where David Coeffic may publish in the future.
Co-authors
The 25 scholars most cited alongside David Coeffic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 110 | |
| 2 | 2014 | 102 | |
| 3 | 2000 | 39 | |
| 4 | 2011 | 28 | |
| 5 | 2012 | 27 | |
| 6 | 2012 | 23 | |
| 7 | 2016 | 23 | |
| 8 | 2001 | 21 | |
| 9 | 2010 | 18 | |
| 10 | 2015 | 14 | |
| 11 | 2011 | 13 | |
| 12 | 2006 | 12 | |
| 13 | 2020 | 7 | |
| 14 | Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances. | 2000 | 6 |
| 15 | European experience with irinotecan plus fluorouracil/folinic acid or mitomycin. | 1998 | 5 |
| 16 | 2011 | 5 | |
| 17 | 2006 | 4 | |
| 18 | Preliminary results of a phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma. | 1997 | 4 |
| 19 | 2013 | 4 | |
| 20 | 2011 | 3 |
About David Coeffic
David Coeffic is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 35 papers that have together received 488 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Breast Cancer Treatment Studies (9 papers), HER2/EGFR in Cancer Research (7 papers), Ovarian cancer diagnosis and treatment (6 papers), Colorectal Cancer Treatments and Studies (3 papers), Neutropenia and Cancer Infections (3 papers), BRCA gene mutations in cancer (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Cancer Research (139 citations), Oncology (234 citations), Reproductive Medicine (45 citations), Radiology, Nuclear Medicine and Imaging (75 citations) and Complementary and alternative medicine (20 citations). David Coeffic has collaborated with scholars based in France, Belgium and Australia. Frequent co-authors include David Khayat, Laurent Arnould, Bruno Coudert, Éric-Charles Antoine, Mario Campone, Frank Priou, Joseph Gligorov, V. Trillet-Lenoir, B. Weber and Moïse Namer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Critical Reviews in Oncology/Hematology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.